Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD14 is a pattern recognition receptor primarily expressed by cells of the innate immune system, especially macrophages and monocytes. It plays a central role in detecting bacterial components and initiating immune responses. CD14 acts as a co-receptor for several Toll-like receptors (TLRs), most notably TLR4, facilitating the detection of pathogen-associated molecular patterns (PAMPs). Therapeutically targeting CD14—for example with anti-CD14 antibodies—has been explored for modulating endotoxin-mediated inflammation in humans.
Modulating endotoxin-mediated inflammation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cluster of Differentiation 14 (CD14).